Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Gwenn Hansen
3 Feb 2026
Chief Scientific Officer
Exercised, kept
31,333
$0.84
$26.32K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 33
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 295,015
History held since 29 Jul 2020